Subcutaneous
drug delivery route has emerged as a promising and viable alternative
to intravenous administration. The demand for subcutaneous delivery
route is attributed to the rapid development of biologics in fastest
growing sector of the pharmaceutical industry. Moreover, the
subcutaneous route of administration is generally preferred, as it
enables self-medication, improves quality of life, and thus reduce
health care costs.
Get
Sample Copy At:
https://www.coherentmarketinsights.com/insight/request-sample/2933
Furthermore,
convenience and safety for both patients and medical professionals
offered by subcutaneous devices are major factors leading to growth
of the global subcutaneous drug delivery market. According to World
Health Organization, 2014, around 2 million healthcare professionals
suffered from infectious diseases as result of needlestick injuries
globally. The retractable nature of prefilled syringes help to
overcome this problem acting as an ideal device to reduce the
occurrence of needlestick injuries.
The
global subcutaneous drug delivery market size was valued at US$
7,077.5 million in 2017 and is expected to exhibit a CAGR of 9.5%
over the forecast period (2018–2026).
Increasing
prevalence of arthritis, multiple sclerosis, and diabetes to propel
the global subcutaneous drug delivery market growth.
Increasing
prevalence of multiple sclerosis (MS), rheumatoid arthritis,
diabetes, and food allergies is expected to drive growth of the
global subcutaneous drug delivery market, as most of the drugs are
administered through subcutaneous drug delivery route. According to
the study by National Multiple Sclerosis Society, 2017, an estimated
1 million people in the U.S. are living with MS, where around
200 new cases are diagnosed each week in the U.S.
According
to the Multiple Sclerosis Trust, 2018, an estimated 2,500,000 people
in the world have multiple sclerosis. According to the Arthritis
Foundation, 2017, around 41 people were diagnosed with Rheumatoid
arthritis (RA) out of every 100,000 people in the U.S. The foundation
further states that about 1.3 million Americans have RA.
According
to the Indian Diabetes Research Foundation, 2016, around 60% of the
world’s population suffering from diabetes lives in Asia, with
around one-half in China and India combined. The foundation also
states that Western Pacific reported over 138.2 million people
suffering from diabetes in 2015, the number for which is expected to
rise to 201.8 million by 2035.
Prevention
of needlestick injuries to bolster the market growth.
Increasing
awareness regarding safety and concern of needlestick injuries is a
major factor driving growth of the global subcutaneous drug delivery
market. According to the Health Protection Agency (HPA) report, in
2012, injuries among medical and dental professionals while treating
patients increased by 131% (100-231) from 2002 to 2011.
Moreover,
preference for safety injection devices is increasing among
healthcare professionals and manufacturers, as these devices decrease
chances of needlestick injuries. For instance, the WHO recommended
the use of safety syringes with sharp injury protection (SIP), in
order to prevent needlestick injuries. Moreover, in May 2017,
Innovative Neurons LLC announced to commercialize its patented auto
retractable multi-needle syringe known as FAST (fast, accessible,
safe, and technology) to decrease needlestick injuries.
Browse
Complete Report For More Information @
https://www.coherentmarketinsights.com/market-insight/subcutaneous-drug-delivery-market-2933
Key
Players
Major
players operating in the global subcutaneous drug delivery market
include Becton Dickinson and Company, Novo Nordisk A/S, Johnson &
Johnson, Sanofi S.A., Novartis International AG, Amgen, Inc., Teva
Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Consort
Medical plc, Eli Lilly and Company, and Merck & Co., Inc.
About
Coherent Market Insights
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us
Mr.
Shah
Coherent
Market Insights
1001
4th Ave, #3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment